Alexander Ross, MD
Cardiovascular Disease · Washington, DCNPI 1831457936
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Intuitive Surgical at 57.9% of the total. Reporting peaked in 2022 at $1,015 and has fallen 85.2% since, to $150 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in DC, where the typical reported total is $1,279.
Across 14 payments — averaging $112.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$915
- Heartflow, Inc.$498
- E.r. Squibb & Sons, L.L.C.$128
- Bracco Diagnostics Inc.$22
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16
What the payments were for
- Travel & lodging$91558%
- Food & beverage$66442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $915 |
| Heartflow, Inc. | 7 | $498 |
| E.r. Squibb & Sons, L.L.C. | 1 | $128 |
| Bracco Diagnostics Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$877
- FFRct$213
How this compares
$1,579 in reported general payments places this provider in the 50th percentile of 105 cardiovascular disease providers in District of Columbia.
See all cardiovascular disease providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 250 | $349,025 |
| EliquisApixaban | 220 | $340,389 |
| XareltoRivaroxaban | 145 | $179,230 |
| EntrestoSacubitril/Valsartan | 66 | $102,937 |
| Repatha SureclickEvolocumab | 74 | $78,892 |
| FarxigaDapagliflozin Propanediol | 30 | $33,394 |
| Telmisartan | 380 | $11,433 |
| Rosuvastatin Calcium | 866 | $11,404 |
| Ezetimibe | 474 | $10,886 |
| Nebivolol Hcl | 137 | $10,576 |
| Eplerenone | 66 | $7,074 |
| PradaxaDabigatran Etexilate Mesylate | 22 | $5,643 |
| Metoprolol Succinate | 372 | $5,044 |
| Carvedilol | 475 | $4,599 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $2,717 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Washington
- Hayder HashimWashington$824K
- Joshua YamamotoWashington$376K
- Mardi Gomberg-MaitlandWashington$320K
- Jaffar KhanWashington$318K
- Isaac Opoku-AsareWashington$146K
- Judith HsiaWashington$65K
- Ana BaracWashington$34K
- Jonathan PlehnWashington$32K
- Andrew ChoiWashington$32K
- Felton AndersonWashington$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.